Skip to main content
Erschienen in: Cancer Causes & Control 8/2009

01.10.2009 | OriginalPaper

Adiposity in relation to colorectal adenomas and hyperplastic polyps in women

verfasst von: Michael F. Leitzmann, Andrew Flood, Leah M. Ferrucci, Philip Schoenfeld, Brooks Cash, Arthur Schatzkin, Amanda J. Cross

Erschienen in: Cancer Causes & Control | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective

To examine whether BMI is independently related to colorectal adenomas and hyperplastic polyps.

Methods

We conducted a cross-sectional study among 1,420 asymptomatic women aged 40–79 years who had undergone complete colonoscopy. Logistic regression was used to estimate the odds ratios (OR) and the corresponding 95% confidence intervals (CI) of adenomas and hyperplastic polyps.

Results

We identified 953 women (67.1%) with no polyps, 292 (20.6%) with adenomas, and 175 (12.3%) with hyperplastic polyps. Among those with polyps, 75 women (5.3% of total women) were classified as having both adenomas and hyperplastic polyps. After adjusting for potential risk factors for colorectal cancer, BMI was related to increased risk of adenomas (OR comparing obese to normal weight women = 1.57; 95% CI = 1.07–2.29). Further, BMI was associated with enhanced risk of hyperplastic polyps (OR = 3.76; 95% CI = 2.35–6.01) and the combination of adenomas and hyperplastic polyps (OR = 2.84; 95% CI = 1.41–5.72).

Conclusions

Excess body mass is positively related to colorectal adenomas and hyperplastic polyps, particularly when both kinds of polyps are present in combination. Future studies should continue to delineate the possible differences in potential risk factors between colorectal adenomas and hyperplastic polyps. Such work should help further elucidate the possible causes of colorectal cancer.
Literatur
1.
Zurück zum Zitat IARC Working Group (2002) IARC handbook of cancer prevention: weight control and physical activity. IARC Press, Lyon IARC Working Group (2002) IARC handbook of cancer prevention: weight control and physical activity. IARC Press, Lyon
4.
Zurück zum Zitat Baron JA (2001) Intermediate effect markers for colorectal cancer. IARC Sci Publ 154:113–129PubMed Baron JA (2001) Intermediate effect markers for colorectal cancer. IARC Sci Publ 154:113–129PubMed
5.
Zurück zum Zitat East JE, Saunders BP, Jass JR (2008) Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 37(1):25–46. doi:10.1016/j.gtc.2007.12.014 PubMedCrossRef East JE, Saunders BP, Jass JR (2008) Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 37(1):25–46. doi:10.​1016/​j.​gtc.​2007.​12.​014 PubMedCrossRef
7.
Zurück zum Zitat Woodson K, Flood A, Green L et al (2004) Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J Natl Cancer Inst 96(5):407–410PubMed Woodson K, Flood A, Green L et al (2004) Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J Natl Cancer Inst 96(5):407–410PubMed
9.
Zurück zum Zitat HO W (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser 854:1–452 HO W (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser 854:1–452
10.
Zurück zum Zitat Honjo S, Kono S, Shinchi K et al (1995) The relation of smoking, alcohol use and obesity to risk of sigmoid colon and rectal adenomas. Jpn J Cancer Res 86(11):1019–1026PubMed Honjo S, Kono S, Shinchi K et al (1995) The relation of smoking, alcohol use and obesity to risk of sigmoid colon and rectal adenomas. Jpn J Cancer Res 86(11):1019–1026PubMed
12.
Zurück zum Zitat Bayerdorffer E, Mannes GA, Ochsenkuhn T, Kopcke W, Wiebecke B, Paumgartner G (1993) Increased risk of ‘high-risk’ colorectal adenomas in overweight men. Gastroenterology 104(1):137–144PubMed Bayerdorffer E, Mannes GA, Ochsenkuhn T, Kopcke W, Wiebecke B, Paumgartner G (1993) Increased risk of ‘high-risk’ colorectal adenomas in overweight men. Gastroenterology 104(1):137–144PubMed
13.
Zurück zum Zitat Davidow AL, Neugut AI, Jacobson JS et al (1996) Recurrent adenomatous polyps and body mass index. Cancer Epidemiol Biomarkers Prev 5(4):313–315PubMed Davidow AL, Neugut AI, Jacobson JS et al (1996) Recurrent adenomatous polyps and body mass index. Cancer Epidemiol Biomarkers Prev 5(4):313–315PubMed
18.
Zurück zum Zitat Shinchi K, Kono S, Honjo S et al (1994) Obesity and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 85(5):479–484PubMed Shinchi K, Kono S, Honjo S et al (1994) Obesity and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 85(5):479–484PubMed
22.
Zurück zum Zitat Bird CL, Frankl HD, Lee ER, Haile RW (1998) Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 147(7):670–680PubMed Bird CL, Frankl HD, Lee ER, Haile RW (1998) Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 147(7):670–680PubMed
23.
25.
Zurück zum Zitat Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C (2002) Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps–a case control study. Eur J Nutr 41(1):35–43. doi:10.1007/s003940200004 PubMedCrossRef Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C (2002) Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps–a case control study. Eur J Nutr 41(1):35–43. doi:10.​1007/​s003940200004 PubMedCrossRef
26.
28.
Zurück zum Zitat Kono S, Handa K, Hayabuchi H et al (1999) Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn J Cancer Res 90(8):805–811PubMed Kono S, Handa K, Hayabuchi H et al (1999) Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn J Cancer Res 90(8):805–811PubMed
29.
Zurück zum Zitat Lubin F, Rozen P, Arieli B et al (1997) Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology. Cancer Epidemiol Biomarkers Prev 6(2):79–85PubMed Lubin F, Rozen P, Arieli B et al (1997) Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology. Cancer Epidemiol Biomarkers Prev 6(2):79–85PubMed
30.
Zurück zum Zitat Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD (2002) Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1012–1018PubMed Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD (2002) Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1012–1018PubMed
32.
Zurück zum Zitat Terry MB, Neugut AI, Bostick RM et al (2002) Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 11(7):622–629PubMed Terry MB, Neugut AI, Bostick RM et al (2002) Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 11(7):622–629PubMed
33.
Zurück zum Zitat Wolf LA, Terry PD, Potter JD, Bostick RM (2007) Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Cancer Epidemiol Biomarkers Prev 16(4):676–683. doi:10.1158/1055-9965.EPI-06-0883 PubMedCrossRef Wolf LA, Terry PD, Potter JD, Bostick RM (2007) Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Cancer Epidemiol Biomarkers Prev 16(4):676–683. doi:10.​1158/​1055-9965.​EPI-06-0883 PubMedCrossRef
34.
Zurück zum Zitat Giovannucci E, Colditz GA, Stampfer MJ, Willett WC (1996) Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 7(2):253–263. doi:10.1007/BF00051301 PubMedCrossRef Giovannucci E, Colditz GA, Stampfer MJ, Willett WC (1996) Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 7(2):253–263. doi:10.​1007/​BF00051301 PubMedCrossRef
35.
36.
Zurück zum Zitat Wise LA, Rosenberg L, Palmer JR, Adams-Campbell LL (2008) Anthropometric risk factors for colorectal polyps in African–American women. Obesity (Silver Spring) 16(4):859–868CrossRef Wise LA, Rosenberg L, Palmer JR, Adams-Campbell LL (2008) Anthropometric risk factors for colorectal polyps in African–American women. Obesity (Silver Spring) 16(4):859–868CrossRef
37.
Zurück zum Zitat Honjo S, Kono S, Shinchi K, Imanishi K, Hirohata T (1992) Cigarette smoking, alcohol use and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 83(8):806–811PubMed Honjo S, Kono S, Shinchi K, Imanishi K, Hirohata T (1992) Cigarette smoking, alcohol use and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 83(8):806–811PubMed
38.
Zurück zum Zitat Young PJ, Robinson EM (1992) Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut 33(11):508–514. doi:10.1136/gut.33.11.1508 Young PJ, Robinson EM (1992) Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut 33(11):508–514. doi:10.​1136/​gut.​33.​11.​1508
41.
Zurück zum Zitat Manus B, Adang RP, Ambergen AW, Bragelmann R, Armbrecht U, Stockbrugger RW (1997) The risk factor profile of recto-sigmoid adenomas: a prospective screening study of 665 patients in a clinical rehabilitation centre. Eur J Cancer Prev 6(1):38–43. doi:10.1097/00008469-199702000-00007 PubMedCrossRef Manus B, Adang RP, Ambergen AW, Bragelmann R, Armbrecht U, Stockbrugger RW (1997) The risk factor profile of recto-sigmoid adenomas: a prospective screening study of 665 patients in a clinical rehabilitation centre. Eur J Cancer Prev 6(1):38–43. doi:10.​1097/​00008469-199702000-00007 PubMedCrossRef
43.
Zurück zum Zitat Hauret KG, Bostick RM, Matthews CE et al (2004) Physical activity and reduced risk of incident sporadic colorectal adenomas: observational support for mechanisms involving energy balance and inflammation modulation. Am J Epidemiol 159(10):983–992. doi:10.1093/aje/kwh130 PubMedCrossRef Hauret KG, Bostick RM, Matthews CE et al (2004) Physical activity and reduced risk of incident sporadic colorectal adenomas: observational support for mechanisms involving energy balance and inflammation modulation. Am J Epidemiol 159(10):983–992. doi:10.​1093/​aje/​kwh130 PubMedCrossRef
44.
Zurück zum Zitat Little J, Logan RF, Hawtin PG, Hardcastle JD, Turner ID (1993) Colorectal adenomas and energy intake, body size and physical activity: a case–control study of subjects participating in the Nottingham faecal occult blood screening programme. Br J Cancer 67(1):172–176PubMed Little J, Logan RF, Hawtin PG, Hardcastle JD, Turner ID (1993) Colorectal adenomas and energy intake, body size and physical activity: a case–control study of subjects participating in the Nottingham faecal occult blood screening programme. Br J Cancer 67(1):172–176PubMed
45.
46.
47.
Zurück zum Zitat Takemura Y, Kikuchi S, Oba K, Inaba Y, Nakagawa K (2000) A high level of physical fitness during thirties is a negative risk factor for colonic polyps during fifties. Keio J Med 49(3):111–116PubMed Takemura Y, Kikuchi S, Oba K, Inaba Y, Nakagawa K (2000) A high level of physical fitness during thirties is a negative risk factor for colonic polyps during fifties. Keio J Med 49(3):111–116PubMed
48.
Zurück zum Zitat Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1995) Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122(5):327–334PubMed Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1995) Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122(5):327–334PubMed
50.
Zurück zum Zitat Stemmermann GN, Heilbrun LK, Nomura AM (1988) Association of diet and other factors with adenomatous polyps of the large bowel: a prospective autopsy study. Am J Clin Nutr 47(2):312–317PubMed Stemmermann GN, Heilbrun LK, Nomura AM (1988) Association of diet and other factors with adenomatous polyps of the large bowel: a prospective autopsy study. Am J Clin Nutr 47(2):312–317PubMed
52.
Zurück zum Zitat Foltyn W, Kos-Kudla B, Strzelczyk J et al (2008) Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly? Neuro Endocrinol Lett 29(1):107–112PubMed Foltyn W, Kos-Kudla B, Strzelczyk J et al (2008) Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly? Neuro Endocrinol Lett 29(1):107–112PubMed
53.
Zurück zum Zitat Warner AS, Glick ME, Fogt F (1994) Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma. Am J Gastroenterol 89(1):123–125PubMed Warner AS, Glick ME, Fogt F (1994) Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma. Am J Gastroenterol 89(1):123–125PubMed
54.
Zurück zum Zitat O’Brien MJ, Yang S, Mack C et al (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30(12):1491–1501. doi:10.1097/01.pas.0000213313.36306.85 PubMedCrossRef O’Brien MJ, Yang S, Mack C et al (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30(12):1491–1501. doi:10.​1097/​01.​pas.​0000213313.​36306.​85 PubMedCrossRef
55.
Zurück zum Zitat Willett WC (1998) Nutritional epidemiology. Oxford University Press, New YorkCrossRef Willett WC (1998) Nutritional epidemiology. Oxford University Press, New YorkCrossRef
56.
Zurück zum Zitat Pischon T, Lahmann PH, Boeing H et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98(13):920–931PubMedCrossRef Pischon T, Lahmann PH, Boeing H et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98(13):920–931PubMedCrossRef
Metadaten
Titel
Adiposity in relation to colorectal adenomas and hyperplastic polyps in women
verfasst von
Michael F. Leitzmann
Andrew Flood
Leah M. Ferrucci
Philip Schoenfeld
Brooks Cash
Arthur Schatzkin
Amanda J. Cross
Publikationsdatum
01.10.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 8/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9346-7

Weitere Artikel der Ausgabe 8/2009

Cancer Causes & Control 8/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.